Home
/
Strata Critical Medical, Inc.
/
Financials
/
Quarterly
Strata Critical Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Strata Critical Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$49.30M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$70.80M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$54.31M
May 12, 2025
Q3
2025
Sep 30, 2024
$36.06M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$67.95M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$51.51M
May 12, 2025
Q3
2024
Sep 30, 2023
$71.44M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$60.99M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$45.27M
May 7, 2024
Q3
2023
Sep 30, 2022
$45.72M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$35.63M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$26.63M
May 11, 2023
Q3
2022
Sep 30, 2021
$20.32M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$12.95M
Aug 9, 2022
Q3
2021
Jun 30, 2021
$12.95M
Aug 16, 2021
Q1
2022
Mar 31, 2021
$9.27M
May 10, 2022
Q3
2021
Jun 30, 2020
$3.44M
Aug 16, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$57.42M
Nov 10, 2025
Q2
2025
Jun 30, 2025
($3.74M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($3.49M)
May 12, 2025
Q3
2025
Sep 30, 2024
($1.95M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($11.33M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($4.23M)
May 12, 2025
Q3
2024
Sep 30, 2023
$289.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.23M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($10.19M)
May 7, 2024
Q3
2023
Sep 30, 2022
($9.25M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
$8.41M
Aug 9, 2023
Q1
2023
Mar 31, 2022
($11.01M)
May 11, 2023
Q3
2022
Sep 30, 2021
($9.18M)
Nov 10, 2022
Q3
2021
Jun 30, 2021
($24.29M)
Aug 16, 2021
Q2
2022
Jun 30, 2021
($24.29M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($4.22M)
May 10, 2022
Q3
2020
Sep 30, 2020
($100.2K)
Nov 10, 2020
Q3
2021
Jun 30, 2020
($1.33M)
Aug 16, 2021
Q2
2020
Jun 30, 2020
($6.0K)
Aug 13, 2020
Q1
2021
Mar 31, 2020
$5.70M
May 24, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.62M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($4.95M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($7.58M)
May 12, 2025
Q3
2025
Sep 30, 2024
($7.09M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($12.15M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($9.87M)
May 12, 2025
Q3
2024
Sep 30, 2023
($7.45M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.21M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($12.83M)
May 7, 2024
Q3
2023
Sep 30, 2022
($10.43M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($9.73M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($13.69M)
May 11, 2023
Q3
2022
Sep 30, 2021
($9.73M)
Nov 10, 2022
Q3
2021
Jun 30, 2021
($7.77M)
Aug 16, 2021
Q2
2022
Jun 30, 2021
($7.77M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($4.23M)
May 10, 2022
Q3
2020
Sep 30, 2020
($160.7K)
Nov 10, 2020
Q3
2021
Jun 30, 2020
($1.48M)
Aug 16, 2021
Q2
2020
Jun 30, 2020
($115.6K)
Aug 13, 2020
Q1
2021
Mar 31, 2020
($145.1K)
May 24, 2021